Showing results (1-10 of 13) with videos related to

Sort By:
Pageof 2
American Journal of Hematology|July 12, 2002
Variation of PDGF, TGFbeta, and bFGF levels in essential thrombocythemia patients treated with anagrelideP R Lev, R F Marta, P Vassallu, et al.
Medicina|February 24, 2001
[Thromboxane B2 and platelet derived growth factor in essential thrombocythemia treated with anagrelide]M S Laguna, L I Kornblihtt, R F Marta, et al.
Clinical and Applied Thrombosis/Hemostasis : Official Journal of the International Academy of Clinical and Applied Thrombosis/Hemostasis|July 18, 2000
Effectiveness of anagrelide in the treatment of symptomatic patients with essential thrombocythemiaM S Laguna, L I Kornblihtt, R F Marta, et al.
The American Journal of Tropical Medicine and Hygiene|February 13, 1999
Proinflammatory cytokines and elastase-alpha-1-antitrypsin in Argentine hemorrhagic feverR F Marta, V S Montero, C E Hack, et al.
Platelets|March 17, 2007
Platelets possess functional TGF-beta receptors and Smad2 proteinP R Lev, J P Salim, R F Marta, et al.
Thrombosis and Haemostasis|March 1, 1995
Early markers of blood coagulation and fibrinolysis activation in Argentine hemorrhagic feverM V Heller, R F Marta, A Sturk, et al.
Journal of Thrombosis and Haemostasis : JTH|January 22, 2015
Anagrelide platelet-lowering effect is due to inhibition of both megakaryocyte maturation and proplatelet formation: insight into potential mechanismsY R Espasandin, A C Glembotsky, M Grodzielski, et al.
Pageof 2